Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 39.88% is 71% above its 5-year average of 23.28%, near the high end of its 5-year range (-11.34%–43.30%).
1.16% above its 12-month average of 39.42%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-07-03): 39.51%.
OPERATING MARGIN
39.88%
OPERATING MARGIN AVG TTM
39.42%
OPERATING MARGIN AVG 3Y
32.00%
OPERATING MARGIN AVG 5Y
23.28%
OPERATING MARGIN AVG 10Y
28.54%
OPERATING MARGIN AVG 15Y
-47.08%
OPERATING MARGIN AVG 20Y
-46.19%
CURRENT VS TTM AVG
+1.16%
CURRENT VS 3Y AVG
+24.61%
CURRENT VS 5Y AVG
+71.31%
CURRENT VS 10Y AVG
+39.72%
CURRENT VS 15Y AVG
+184.70%
CURRENT VS 20Y AVG
+186.35%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Exelixis, Inc.
Market Cap
$14.70B
Operating Margin
39.88%
TTM Avg
39.42%
3Y Avg
32.00%
5Y Avg
23.28%
Market Cap
$14.61B
Operating Margin
5.26%
TTM Avg
11.43%
3Y Avg
9.04%
5Y Avg
9.61%
Market Cap
$14.52B
Operating Margin
23.38%
TTM Avg
22.93%
3Y Avg
18.97%
5Y Avg
16.75%
Market Cap
$14.77B
Operating Margin
12.35%
TTM Avg
9.13%
3Y Avg
12.39%
5Y Avg
13.51%
Market Cap
$14.25B
Operating Margin
-18.92%
TTM Avg
-47.79%
3Y Avg
-341.06%
5Y Avg
-1987.98%
Market Cap
$15.06B
Operating Margin
24.99%
TTM Avg
19.38%
3Y Avg
20.05%
5Y Avg
20.47%
Market Cap
$13.62B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-2556.35%
5Y Avg
-4397.07%
Market Cap
$13.20B
Operating Margin
-113.35%
TTM Avg
-190.29%
3Y Avg
-1892.24%
5Y Avg
-2358.01%
Market Cap
$13.13B
Operating Margin
56.77%
TTM Avg
56.39%
3Y Avg
48.50%
5Y Avg
51.69%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Exelixis, Inc. (EXEL) | $14.70B | 39.88% | 39.42% | 32.00% | 23.28% |
| Jazz Pharmaceuticals plc (JAZZ)vs › | $14.61B | 5.26% | 11.43% | 9.04% | 9.61% |
| Neurocrine Biosciences, Inc. (NBIX)vs › | $14.52B | 23.38% | 22.93% | 18.97% | 16.75% |
| Charles River Laboratories International, Inc. (CRL)vs › | $14.77B | 12.35% | 9.13% | 12.39% | 13.51% |
| Ascendis Pharma A/S (ASND)vs › | $14.25B | -18.92% | -47.79% | -341.06% | -1987.98% |
| Solventum Corporation (SOLV)vs › | $15.06B | 24.99% | 19.38% | 20.05% | 20.47% |
| Summit Therapeutics Inc. (SMMT)vs › | $13.62B | 0.00% | 0.00% | -2556.35% | -4397.07% |
| BridgeBio Pharma, Inc. (BBIO)vs › | $13.20B | -113.35% | -190.29% | -1892.24% | -2358.01% |
| Halozyme Therapeutics, Inc. (HALO)vs › | $13.13B | 56.77% | 56.39% | 48.50% | 51.69% |
| Corcept Therapeutics Incorporated (CORT)vs › | $12.88B | 0.77% | 13.08% | 19.11% | 24.45% |
Gross Margin
96.5%
Operating Margin
39.9%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-07-03 | 39.51% |
| 2026-04-03 | 41.15% |
| 2026-01-02 | 39.29% |
| 2025-10-03 | 39.57% |
| 2025-07-04 | 37.58% |
| 2025-04-04 | 33.64% |
| 2024-12-31 | 28.80% |
| 2024-09-27 | 25.22% |
| 2024-06-28 | 43.30% |
| 2024-03-29 | 6.93% |
| 2023-12-31 | 17.05% |
| 2023-09-29 | -3.73% |
| 2023-06-30 | 16.57% |
| 2023-03-31 | 7.05% |
| 2022-12-31 | -11.34% |
| 2022-09-30 | 20.06% |
| 2022-07-01 | 19.96% |
| 2022-04-01 | 23.38% |
| 2021-12-31 | 25.86% |
| 2021-10-01 | 15.72% |
| 2021-07-02 | 31.94% |
| 2021-04-02 | -1.70% |
| 2020-12-31 | 9.00% |
| 2020-10-02 | -18.43% |
| 2020-07-03 | 29.11% |
| 2020-04-03 | 23.27% |
| 2019-12-31 | 32.17% |
| 2019-09-27 | 42.55% |
| 2019-06-28 | 38.28% |
| 2019-03-29 | 39.24% |
| 2018-12-31 | 48.82% |
| 2018-09-28 | 55.54% |
| 2018-06-29 | 46.09% |
| 2018-03-30 | 54.77% |
| 2017-12-31 | 31.17% |
| 2017-09-29 | 53.23% |
| 2017-06-30 | 27.38% |
| 2017-03-31 | 24.96% |
| 2016-12-31 | 50.12% |
| 2016-09-30 | 11.68% |
| 2016-07-01 | -69.34% |
| 2016-04-01 | -318.50% |
| 2015-12-31 | -317.97% |
| 2015-10-02 | -363.11% |
| 2015-07-03 | -391.39% |
| 2015-04-03 | -242.44% |
| 2014-12-31 | -628.42% |
| 2014-09-26 | -819.81% |
| 2014-06-27 | -940.08% |
| 2014-03-28 | -1324.93% |
| 2013-12-31 | -1369.08% |
| 2013-09-27 | -1022.92% |
| 2013-06-28 | -432.65% |
| 2013-03-29 | -351.74% |
| 2012-12-31 | -537.16% |
| 2012-09-30 | -191.11% |
| 2012-06-29 | -418.83% |
| 2012-03-30 | -120.45% |
| 2011-12-31 | 55.27% |
| 2011-09-30 | 62.13% |
| 2011-07-01 | -55.99% |
| 2011-04-01 | -66.11% |
| 2010-12-31 | -34.60% |
| 2010-10-01 | -7.72% |
| 2010-07-02 | -53.85% |
| 2010-04-02 | -112.45% |
| 2009-12-31 | -68.75% |
| 2009-10-02 | -30.59% |
| 2009-07-03 | -138.72% |
| 2009-04-03 | -145.34% |
| 2008-12-31 | -132.90% |
| 2008-09-26 | -149.02% |
| 2008-06-27 | -160.08% |
| 2008-03-28 | -167.19% |
| 2007-12-31 | -146.19% |
| 2007-09-28 | -158.90% |
| 2007-06-29 | -130.91% |
| 2007-03-30 | -118.56% |
| 2006-12-31 | -113.38% |
| 2006-09-30 | -134.07% |
| 2006-06-30 | -111.54% |
| 2006-03-31 | -171.41% |
| 2005-12-31 | -205.16% |
| 2005-09-30 | -193.69% |
| 2005-06-30 | -28.10% |
| 2005-03-31 | -209.42% |
| 2004-12-31 | -324.53% |
| 2004-09-30 | -210.38% |
| 2004-06-30 | -229.79% |
| 2004-03-31 | -240.59% |
| 2003-12-31 | -170.78% |
| 2003-09-30 | -201.99% |
| 2003-06-30 | -186.97% |
| 2003-03-31 | -189.03% |
| 2002-12-31 | -168.17% |
| 2002-09-30 | -220.29% |
